MET and anaplastic large cell lymphoma: Since it was reported that c-Met harbors the ability to control the ROS generation and contributes in the oncogenicity of ALCL-derived cell lines [34, 35], it is also suggested that the involvement of c-Met could be a reason for the different responses against the treatment of crizotinib in between ALCL-derived cell lines and Ba/F3 cells.